Outset Medical (OM)
Provides the Tablo hemodialysis platform for hospital, clinic, and home care.
$3.17
vs last close−0.12 (−3.72%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 73.67% | 13.85M shares | |
|---|---|---|---|
| 95 holders · as of Jun 30, 2026 | |||
| Insiders | 5.68% | 1.07M shares | |
| 13 holders · as of Aug 18, 2026 | |||
| Other | 20.65% | 3.88M shares | |
| remainder | |||
18.80M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
95 holders · 13.85M shares · 20 new positions · 51 increased · 28 reduced · 24 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 2.74M | 14.59% | +1.2K | Aug 13, 2026 |
| BML Capital Management, LLC | 2.52M | 13.40% | +617.5K | Aug 7, 2026 |
| AQR Capital Management LLC | 999.0K | 5.31% | +190.7K | Aug 14, 2026 |
| Perceptive Advisors LLC | 833.3K | 4.43% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 780.1K | 4.15% | +16.3K | Aug 13, 2026 |
| Bank of America Corp /DE/ | 665.8K | 3.54% | −283.6K | Aug 14, 2026 |
| PFM Health Sciences, LP | 582.1K | 3.10% | −12.5K | Aug 14, 2026 |
| Ensign Peak Advisors, Inc | 434.3K | 2.31% | −92.2K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 14.50% | 2.60M | 13G | Apr 7, 2025 |
| BML Investment Partners, L.P. | 13.60% | 2.52M | 13G | May 18, 2026 |
| Durable Capital Partners LP | 9.90% | 13G | Jan 10, 2025 | |
| Alyeska Investment Group, L.P. | 9.61% | 1.70M | 13G | May 15, 2025 |
| Perceptive Advisors LLC | 9.50% | 13G | Feb 28, 2025 | |
| BlackRock, Inc. | 6.80% | 1.21M | 13G | Oct 17, 2025 |
| AQR Capital Management, LLC | 5.39% | 999.0K | 13G | Aug 12, 2026 |
| Bank of America Corp /DE/ | 5.20% | 950.6K | 13G | Feb 11, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 17, 2026 | Leslie Triggdirector, officer: Chair and CEO | Sale | 3,437 | $4.39 | 194,597 |
| Aug 17, 2026 | John L. Brottemofficer: General Counsel | Sale | 2,632 | $4.39 | 87,475 |
| Aug 17, 2026 | Renee Gaetaofficer: Chief Financial Officer | Sale | 4,543 | $4.39 | 180,840 |
| Jun 3, 2026 | Renee Gaetaofficer: Chief Financial Officer | Sale | 17,672 | $4.94 | 113,753 |
| May 15, 2026 | John L. Brottemofficer: General Counsel | Sale | 2,638 | $3.70 | 30,277 |
| May 15, 2026 | Marc Nashofficer: EVP Operations R&D & Service | Sale | 1,582 | $3.70 | 38,393 |
| May 15, 2026 | Leslie Triggdirector, officer: Chair and CEO | Sale | 3,445 | $3.70 | 98,874 |
| Feb 17, 2026 | Marc Nashofficer: EVP Operations R&D & Service | Sale | 1,817 | $3.35 | 39,988 |
| Feb 17, 2026 | Leslie Triggdirector, officer: Chair and CEO | Sale | 3,361 | $3.35 | 102,342 |
| Feb 17, 2026 | John L. Brottemofficer: General Counsel | Sale | 2,842 | $3.35 | 32,935 |
House and Senate disclosures
Not reported.